'Risk benefit assessment' diaporamas de présentation

THE CHANGING SHAPE OF PHARMACEUTICAL RISK

315 views • 21 slides

WP 5: Progress on tasks 5.2, 5.3 and 5.4

WP 5: Progress on tasks 5.2, 5.3 and 5.4. Olli Leino THL. Tasks. 5.2: Tiered methodology for risk benefit assessment 5.3: Review on available Methodology for validation of risk, benefit and risk- benefit assessment 5.4: Identification of common currency. http://en.opasnet.org/w/Opasnet

289 views • 17 slides

Risk/Benefit Assessment

Risk/Benefit Assessment. Jeremy N. Ruskin, M.D. Director, Cardiac Arrhythmia Services Massachusetts General Hospital. AF Population Baseline Characteristics. Nieuwlaat R et al. Eur Heart J. 2005; 26:2422-34 The AFFIRM Writing Group N Engl J Med, 2002;347:1825-33.

186 views • 9 slides